Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus.
about
Intrathecal long-term gene expression by self-complementary adeno-associated virus type 1 suitable for chronic pain studies in ratsHSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain.Gene doping: gene delivery for olympic victoryOptogenetic control of targeted peripheral axons in freely moving animalsASIC3 in muscle mediates mechanical, but not heat, hyperalgesia associated with muscle inflammationContinuous delta-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathyAttenuation of myogenic orofacial nociception and mechanical hypersensitivity by viral mediated enkephalin overproduction in male and female ratsGene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalinPseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry.Gene therapy in the CNS.Emerging cell and molecular strategies for the study and treatment of painful peripheral neuropathies.Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.HSV delivery of a ligand-regulated endogenous ion channel gene to sensory neurons results in pain control following channel activation.Regulated proenkephalin expression in human skin and cultured skin cellsAdeno-associated viral transfer of opioid receptor gene to primary sensory neurons: a strategy to increase opioid antinociception.Relief of pain induced by varicella-zoster virus in a rat model of post-herpetic neuralgia using a herpes simplex virus vector expressing enkephalin.When the DREAM is gone: from basic science to future prospectives in pain management and beyond.Vectors for the treatment of autoimmune disease.Gene therapy for pain: results of a phase I clinical trial.Injury-specific promoters enhance herpes simplex virus-mediated gene therapy for treating neuropathic pain in rodentsDevelopment of viral vectors for gene therapy for chronic painExploiting the neurotherapeutic potential of peptides: targeted delivery using HSV vectors.Current gene therapy using viral vectors for chronic painHerpes simplex virus-based vectors.Gene therapy applications of viral vectors.Construction and characterization of a herpes simplex virus type I recombinant expressing green fluorescent protein: acute phase replication and reactivation in miceHSV trafficking and development of gene therapy vectors with applications in the nervous system.Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociceptionHSV vector-mediated GAD67 suppresses neuropathic pain induced by perineural HIV gp120 in rats through inhibition of ROS and Wnt5aViral vector-based gene transfer for treatment of chronic pain.Gene therapy applications for the treatment of neuropathic pain.Efficacy of Herpes Simplex Virus Vector Encoding the Human Preproenkephalin Gene for Treatment of Facial Pain in Mice.Herpes vector-mediated gene transfer in the treatment of chronic painApplications of gene therapy to the treatment of chronic pain.Gene therapy directed at the neuroimmune component of chronic pain with particular attention to the role of TNF alpha.A human trial of HSV-mediated gene transfer for the treatment of chronic pain.Dose-dependent effects of icilin on thermal preference in the hindpaw and face of rats.Recombinant adeno-associated virus serotype 6 (rAAV2/6)-mediated gene transfer to nociceptive neurons through different routes of delivery.Herpes virus-based recombinant herpes vectors: gene therapy for pain and molecular tool for pain science.Gene therapy for pancreatitis pain.
P2860
Q25256466-FE3D33CB-D4BF-47C1-B1F7-16F127DD4432Q25257395-01F92BF2-8AFB-45AA-9749-D2DA8D5BA23EQ26995443-4FAE48F4-FE71-443F-8196-AE776C934958Q27308829-AC30FEBD-E311-4A51-B0B3-3DAE24A545A1Q28396483-AA28529D-7D40-459B-87CB-62E223AB65E8Q28580927-6F4DDC28-F80B-4F4E-A1C4-1141032DE084Q30630884-8232CAFB-D0C1-449F-9B72-4E3CC8A21885Q33792025-BC5AEF80-DD9C-4F30-BAAA-499A3A130776Q33799437-97570F73-2C84-4DD2-9D70-5D6A9A2827B0Q33837123-36E92A7C-ADC3-4F49-B8D7-F6BD23C69F52Q33975112-B03EFA19-41C6-4146-B0A0-3A7E13486B2BQ34062737-3B3B66E8-1786-40B2-B6B8-E4C672A11AF1Q34621676-BB937125-A145-4BF5-ABF8-41DED78E822EQ34783756-48B22ACE-925B-477C-B261-BBA3994AE5B1Q35023218-7FF125B4-E48F-4EE8-8D64-A8F0D905E24BQ35073428-E71FACE3-F009-45E3-AF2F-868481430BA5Q35095159-9DD9F25C-7206-465A-8E36-A7EFA854959EQ35122178-39E60B65-32F4-4640-A6B3-86DAD7ADAEA0Q35154100-D031E99E-F206-43EF-8135-03930F0DEAA3Q35155806-2BA3BDD8-D951-4834-B18C-B072E790B017Q35430864-DEF32638-95C3-4A2B-8F72-463F1F078AA5Q35594068-6DCC53E1-F353-4831-9C70-D078A02B615BQ35658521-4E70A303-6300-4C2A-80C6-DA538606BA3CQ35863367-9C0688FA-D391-4ED1-BDDB-EAB07E8E74CDQ35904004-F14C0AF2-A76D-421A-9D4D-A84D1868AF67Q35989192-CF75C0B9-8C5F-4742-9821-FEB6C3CA0C06Q36134871-DEE7CFA6-F163-407E-93D7-E9C7CC09D918Q36634794-9C795D85-3F12-43BF-A97C-C66B2AB936CCQ36777541-CA9CBF7B-A41E-4343-8CC0-92C56197A89FQ36787828-57E472CA-AB9A-4966-AA06-FD9B7E2C295FQ36817045-B69E4BA3-5D5E-4F5D-A8C5-A730017BE107Q36921432-2BE4C939-C58B-4DFE-A9B5-9C41AA9E4A22Q37035292-1958519E-11CC-4463-A155-44C369F7C7BCQ37108334-57359D82-7BB9-4DF2-BEAD-7C26DA7E0AFCQ37134881-749F9845-F616-425F-B074-B0BE14D5F9ADQ37195741-E2E14744-158B-4983-8EA3-0FEE5CEFBBDBQ37317501-8DC68AAE-808C-4A18-9E16-C63856D9FDE2Q37355740-BBF3F436-3299-471E-B027-495CD911C3EFQ37395773-2276739E-D250-4F6F-B2C2-2CD96F44B9D9Q37406982-9358E8A5-8C4D-4CA2-A846-2BA31E46EC6D
P2860
Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus.
@ast
Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus.
@en
type
label
Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus.
@ast
Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus.
@en
prefLabel
Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus.
@ast
Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus.
@en
P2093
P2860
P356
P1476
Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus.
@en
P2093
P2860
P304
P356
10.1073/PNAS.96.6.3211
P407
P577
1999-03-01T00:00:00Z